Article

Spinocerebellar ataxia type 2 olfactory impairment shows a pattern similar to other major neurodegenerative diseases.

Centro para la Investigación y Rehabilitación de las Ataxias Hereditarias Carlos J. Finlay, Holguín, Cuba.
Journal of Neurology (Impact Factor: 3.84). 10/2006; 253(9):1165-9. DOI: 10.1007/s00415-006-0183-2
Source: PubMed

ABSTRACT Olfactory function is affected in different neurodegenerative diseases. Recently, it has been found that some hereditary ataxias are also associated with significant olfactory impairment. However, the initial findings did not examine the nature of the olfactory impairment associated with these ataxias. In the present article the effect of spinocerebellar ataxia type 2 (SCA2) on olfactory function was studied in 53 SCA2 patients and 53 healthy control subjects from Holguín, Cuba. Several tests were applied to evaluate olfactory threshold, description, identification and discrimination. The results show significant impairment in SCA2 patients on all olfactory measurements, and the pattern of olfactory deficits found suggests that they have much in common with those reported for other neurodegenerative diseases such as Parkinson's and Alzheimer's diseases.

0 Bookmarks
 · 
108 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Abstract Anomalies in the oculomotor system are well known symptoms in different neurodegenerative diseases. It has been found that patients suffering from severe spino cerebellar ataxia type 2 show deterioration in the main parameters used to describe saccadic movements, specifically the slowing of horizontal saccadic eye movements. Besides, a combination of two components, named pulse and step, constitutes an accepted model of the saccadic generation system. In the present work, independent component analysis is applied in order to separate both pulse and step components, revealing significant differences in several parameters related to the morphology of these components between patients and control responses. Ten electro-oculographic records of spino cerebellar ataxia type 2 patients and ten control subjects were processed with the proposed algorithm with the aim of obtaining a correct diagnosis. The results obtained from these real experiments reveal the validity of the proposed approach as a classification tool for the diagnosis of this disease.
    Neurocomputing 12/2013; 121. · 2.01 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Resumen La ataxia espinocerebelosa tipo 2 (SCA2) es una enfermedad genética con un patrón de herencia autosómico dominante que se caracteriza por atrofia cerebelosa asociada con movimientos sacádicos lentos, hiporreflexia temprana, temblor postural severo, neuropatía periférica, desórdenes cognitivos y otras características multisistémicas. La SCA2, una de las ataxias más comunes a nivel mundial, es causada por la expansión anormal de un triplete repetido CAG presente en el gen ATXN2. Los pacientes con SCA2 presentan más de 32 y hasta cientos de repetidos CAG. En esta revisión se ofrece una descripción detallada de las principales carac-terísticas epidemiológicas, clínicas y genéticas de la SCA2. Asimismo se detalla la experiencia de la aplicación de programas de diagnóstico predictivo en la población cubana, en donde la caracterización de las manifestaciones clínicas de la SCA2, en conjunto con el diagnóstico molecular oportuno, han permitido establecer esquemas de rehabilitación para estos pacientes. Abstract Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant genetic disease characterized by cerebellar dysfunction associated with slow saccades, early hyporeflexia, severe tremor of postural or action type, peripheral neuropathy, cognitive disorders, and other multisystemic features. Currently SCA2 is considered one of the most common ataxias worldwide. SCA2 is a polyglutamine disease caused by the abnormal expansion of CAG triplet repeat located in the ATXN2 gene. Affected individuals carry more than 32 and up to several hundred of CAG repeats. In this review we present a detailed description of epidemiology, clinical, genetic, electrophysiological and neuropathological characteristics of SCA2. The experience in apply-ing early molecular diagnosis and a predictive diagnosis program in Cuba have allowed the establishment of rehabilitation programs for patients with SCA2.
    09/2014; 3(3):114-122.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Olfactory dysfunction is a common and early symptom of many neurodegenerative diseases, particularly of Parkinson's disease and other synucleinopathies, Alzheimer's disease (AD), and mild cognitive impairment heralding its progression to dementia. The neuropathologic changes of olfactory dysfunction in neurodegenerative diseases may involve the olfactory epithelium, olfactory bulb/tract, primary olfactory cortices, and their secondary targets. Olfactory dysfunction is related to deposition of pathological proteins, α-synuclein, hyperphosphorylated tau protein, and neurofilament protein in these areas, featured by neurofibrillary tangles, Lewy bodies and neurites inducing a complex cascade of molecular processes including oxidative damage, neuroinflammation, and cytosolic disruption of cellular processes leading to cell death. Damage to cholinergic, serotonergic, and noradrenergic systems is likely involved, since such damage is most marked in those diseases with severe anosmia. Recent studies of olfactory dysfunction have focused its potential as an early biomarker for the diagnosis of neurodegenerative disorders and their disease progression. Here, we summarize the current knowledge on neuropathological and pathophysiological changes of the olfactory system in the most frequent neurodegenerative diseases, in particular AD and synucleinopathies. We also present neuropathological findings in the olfactory bulb and tract in a large autopsy cohort (n = 536, 57.8 % female, mean age 81.3 years). The severity of olfactory bulb HPτ, Aβ, and αSyn pathology correlated and increased significantly (P < 0.001) with increasing neuritic Braak stages, Thal Aβ phases, and cerebral Lewy body pathology, respectively. Hence, further studies are warranted to investigate the potential role of olfactory biopsies (possibly restricted to the olfactory epithelium) in the diagnostic process of neurodegenerative diseases in particular in clinical drug trials to identify subjects showing early, preclinical stages of neurodegeneration and to stratify clinically impaired cohorts according to the underlying cerebral neuropathology.
    Acta Neuropathologica 02/2014; 127(4). · 9.78 Impact Factor

Full-text

Download
46 Downloads
Available from
Jun 1, 2014